A citation-based method for searching scientific literature

Emanuele Mazzola, Jonathan Chipman, Su-Chun Cheng, Giovanni Parmigiani. Cancer Epidemiol Biomarkers Prev 2014
Times Cited: 14







List of co-cited articles
65 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity



A breast cancer prediction model incorporating familial and personal risk factors.
Jonathan Tyrer, Stephen W Duffy, Jack Cuzick. Stat Med 2004
657
50

The BOADICEA model of genetic susceptibility to breast and ovarian cancers: updates and extensions.
A C Antoniou, A P Cunningham, J Peto, D G Evans, F Lalloo, S A Narod, H A Risch, J E Eyfjord, J L Hopper, M C Southey,[...]. Br J Cancer 2008
302
35

Risks of Breast, Ovarian, and Contralateral Breast Cancer for BRCA1 and BRCA2 Mutation Carriers.
Karoline B Kuchenbaecker, John L Hopper, Daniel R Barnes, Kelly-Anne Phillips, Thea M Mooij, Marie-José Roos-Blom, Sarah Jervis, Flora E van Leeuwen, Roger L Milne, Nadine Andrieu,[...]. JAMA 2017
828
35

Projecting individualized probabilities of developing breast cancer for white females who are being examined annually.
M H Gail, L A Brinton, D P Byar, D K Corle, S B Green, C Schairer, J J Mulvihill. J Natl Cancer Inst 1989
28

Evaluation of breast cancer risk assessment packages in the family history evaluation and screening programme.
E Amir, D G Evans, A Shenton, F Lalloo, A Moran, C Boggis, M Wilson, A Howell. J Med Genet 2003
182
28

The risk of cancer associated with specific mutations of BRCA1 and BRCA2 among Ashkenazi Jews.
J P Struewing, P Hartge, S Wacholder, S M Baker, M Berlin, M McAdams, M M Timmerman, L C Brody, M A Tucker. N Engl J Med 1997
28

The BOADICEA model of genetic susceptibility to breast and ovarian cancer.
A C Antoniou, P P D Pharoah, P Smith, D F Easton. Br J Cancer 2004
286
28

Population-based screening for BRCA1 and BRCA2: 2014 Lasker Award.
Mary-Claire King, Ephrat Levy-Lahad, Amnon Lahad. JAMA 2014
174
28

Population testing for cancer predisposing BRCA1/BRCA2 mutations in the Ashkenazi-Jewish community: a randomized controlled trial.
Ranjit Manchanda, Kelly Loggenberg, Saskia Sanderson, Matthew Burnell, Jane Wardle, Sue Gessler, Lucy Side, Nyala Balogun, Rakshit Desai, Ajith Kumar,[...]. J Natl Cancer Inst 2014
105
28

Cost-effectiveness of Population-Based BRCA1, BRCA2, RAD51C, RAD51D, BRIP1, PALB2 Mutation Testing in Unselected General Population Women.
Ranjit Manchanda, Shreeya Patel, Vladimir S Gordeev, Antonis C Antoniou, Shantel Smith, Andrew Lee, John L Hopper, Robert J MacInnis, Clare Turnbull, Susan J Ramus,[...]. J Natl Cancer Inst 2018
76
28

Population-based screening for breast and ovarian cancer risk due to BRCA1 and BRCA2.
Efrat Gabai-Kapara, Amnon Lahad, Bella Kaufman, Eitan Friedman, Shlomo Segev, Paul Renbaum, Rachel Beeri, Moran Gal, Julia Grinshpun-Cohen, Karen Djemal,[...]. Proc Natl Acad Sci U S A 2014
191
28


BOADICEA breast cancer risk prediction model: updates to cancer incidences, tumour pathology and web interface.
A J Lee, A P Cunningham, K B Kuchenbaecker, N Mavaddat, D F Easton, A C Antoniou. Br J Cancer 2014
135
21


American Cancer Society guidelines for breast screening with MRI as an adjunct to mammography.
Debbie Saslow, Carla Boetes, Wylie Burke, Steven Harms, Martin O Leach, Constance D Lehman, Elizabeth Morris, Etta Pisano, Mitchell Schnall, Stephen Sener,[...]. CA Cancer J Clin 2007
21

Cost-effectiveness of population screening for BRCA mutations in Ashkenazi jewish women compared with family history-based testing.
Ranjit Manchanda, Rosa Legood, Matthew Burnell, Alistair McGuire, Maria Raikou, Kelly Loggenberg, Jane Wardle, Saskia Sanderson, Sue Gessler, Lucy Side,[...]. J Natl Cancer Inst 2014
97
21

A study of over 35,000 women with breast cancer tested with a 25-gene panel of hereditary cancer genes.
Saundra S Buys, John F Sandbach, Amanda Gammon, Gayle Patel, John Kidd, Krystal L Brown, Lavania Sharma, Jennifer Saam, Johnathan Lancaster, Mary B Daly. Cancer 2017
177
21

Breast cancer risk assessment across the risk continuum: genetic and nongenetic risk factors contributing to differential model performance.
Anne S Quante, Alice S Whittemore, Tom Shriver, Konstantin Strauch, Mary B Terry. Breast Cancer Res 2012
69
14


Breast cancer risk prediction accuracy in Jewish Israeli high-risk women using the BOADICEA and IBIS risk models.
Yael Laitman, Monica Simeonov, Lital Keinan-Boker, Irena Liphshitz, Eitan Friedman. Genet Res (Camb) 2013
10
20


Prospective validation of the breast cancer risk prediction model BOADICEA and a batch-mode version BOADICEACentre.
R J MacInnis, A Bickerstaffe, C Apicella, G S Dite, J G Dowty, K Aujard, K-A Phillips, P Weideman, A Lee, M B Terry,[...]. Br J Cancer 2013
31
14

Common genetic variants and modification of penetrance of BRCA2-associated breast cancer.
Mia M Gaudet, Tomas Kirchhoff, Todd Green, Joseph Vijai, Joshua M Korn, Candace Guiducci, Ayellet V Segrè, Kate McGee, Lesley McGuffog, Christiana Kartsonaki,[...]. PLoS Genet 2010
66
14

Modifiers of cancer risk in BRCA1 and BRCA2 mutation carriers: systematic review and meta-analysis.
Tara M Friebel, Susan M Domchek, Timothy R Rebbeck. J Natl Cancer Inst 2014
114
14

Characterization of BRCA1 and BRCA2 mutations in a large United States sample.
Sining Chen, Edwin S Iversen, Tara Friebel, Dianne Finkelstein, Barbara L Weber, Andrea Eisen, Leif E Peterson, Joellen M Schildkraut, Claudine Isaacs, Beth N Peshkin,[...]. J Clin Oncol 2006
218
14

Breast cancer risk associated with BRCA1 and BRCA2 in diverse populations.
James D Fackenthal, Olufunmilayo I Olopade. Nat Rev Cancer 2007
283
14



Tailoring BRCAPRO to Asian-Americans.
Sining Chen, Amanda L Blackford, Giovanni Parmigiani. J Clin Oncol 2009
12
16

Assessing the added value of breast tumor markers in genetic risk prediction model BRCAPRO.
Swati Biswas, Neelam Tankhiwale, Amanda Blackford, Angelica M Gutierrez Barrera, Kaylene Ready, Karen Lu, Christopher I Amos, Giovanni Parmigiani, Banu Arun. Breast Cancer Res Treat 2012
16
14

BayesMendel: an R environment for Mendelian risk prediction.
Sining Chen, Wenyi Wang, Karl W Broman, Hormuzd A Katki, Giovanni Parmigiani. Stat Appl Genet Mol Biol 2004
51
14

Assessment of clinical validity of a breast cancer risk model combining genetic and clinical information.
Matthew E Mealiffe, Renee P Stokowski, Brian K Rhees, Ross L Prentice, Mary Pettinger, David A Hinds. J Natl Cancer Inst 2010
115
14

Discriminatory accuracy and potential clinical utility of genomic profiling for breast cancer risk in BRCA-negative women.
E Comen, L Balistreri, M Gönen, A Dutra-Clarke, M Fazio, J Vijai, Z Stadler, N Kauff, T Kirchhoff, C Hudis,[...]. Breast Cancer Res Treat 2011
13
15

The contributions of breast density and common genetic variation to breast cancer risk.
Celine M Vachon, V Shane Pankratz, Christopher G Scott, Lothar Haeberle, Elad Ziv, Matthew R Jensen, Kathleen R Brandt, Dana H Whaley, Janet E Olson, Katharina Heusinger,[...]. J Natl Cancer Inst 2015
111
14

The Breast Cancer Family Registry: an infrastructure for cooperative multinational, interdisciplinary and translational studies of the genetic epidemiology of breast cancer.
Esther M John, John L Hopper, Jeanne C Beck, Julia A Knight, Susan L Neuhausen, Ruby T Senie, Argyrios Ziogas, Irene L Andrulis, Hoda Anton-Culver, Norman Boyd,[...]. Breast Cancer Res 2004
233
14

Prediction of breast cancer risk based on profiling with common genetic variants.
Nasim Mavaddat, Paul D P Pharoah, Kyriaki Michailidou, Jonathan Tyrer, Mark N Brook, Manjeet K Bolla, Qin Wang, Joe Dennis, Alison M Dunning, Mitul Shah,[...]. J Natl Cancer Inst 2015
305
14

Performance of common genetic variants in breast-cancer risk models.
Sholom Wacholder, Patricia Hartge, Ross Prentice, Montserrat Garcia-Closas, Heather Spencer Feigelson, W Ryan Diver, Michael J Thun, David G Cox, Susan E Hankinson, Peter Kraft,[...]. N Engl J Med 2010
319
14


Risk assessment, genetic counseling, and genetic testing for BRCA-related cancer in women: a systematic review to update the U.S. Preventive Services Task Force recommendation.
Heidi D Nelson, Miranda Pappas, Bernadette Zakher, Jennifer Priest Mitchell, Leila Okinaka-Hu, Rongwei Fu. Ann Intern Med 2014
153
14

Randomized noninferiority trial of telephone versus in-person genetic counseling for hereditary breast and ovarian cancer.
Marc D Schwartz, Heiddis B Valdimarsdottir, Beth N Peshkin, Jeanne Mandelblatt, Rachel Nusbaum, An-Tsun Huang, Yaojen Chang, Kristi Graves, Claudine Isaacs, Marie Wood,[...]. J Clin Oncol 2014
155
14

Pathology of breast and ovarian cancers among BRCA1 and BRCA2 mutation carriers: results from the Consortium of Investigators of Modifiers of BRCA1/2 (CIMBA).
Nasim Mavaddat, Daniel Barrowdale, Irene L Andrulis, Susan M Domchek, Diana Eccles, Heli Nevanlinna, Susan J Ramus, Amanda Spurdle, Mark Robson, Mark Sherman,[...]. Cancer Epidemiol Biomarkers Prev 2012
322
14

Breast cancer risk-assessment models.
D Gareth R Evans, Anthony Howell. Breast Cancer Res 2007
80
14

Validity of models for predicting BRCA1 and BRCA2 mutations.
Giovanni Parmigiani, Sining Chen, Edwin S Iversen, Tara M Friebel, Dianne M Finkelstein, Hoda Anton-Culver, Argyrios Ziogas, Barbara L Weber, Andrea Eisen, Kathleen E Malone,[...]. Ann Intern Med 2007
74
14

Cumulative probability of false-positive recall or biopsy recommendation after 10 years of screening mammography: a cohort study.
Rebecca A Hubbard, Karla Kerlikowske, Chris I Flowers, Bonnie C Yankaskas, Weiwei Zhu, Diana L Miglioretti. Ann Intern Med 2011
240
14

Modifiers of breast and ovarian cancer risks for BRCA1 and BRCA2 mutation carriers.
Roger L Milne, Antonis C Antoniou. Endocr Relat Cancer 2016
35
14

The carrier frequency of the BRCA2 6174delT mutation among Ashkenazi Jewish individuals is approximately 1%.
C Oddoux, J P Struewing, C M Clayton, S Neuhausen, L C Brody, M Kaback, B Haas, L Norton, P Borgen, S Jhanwar,[...]. Nat Genet 1996
297
14

Detection of inherited mutations for breast and ovarian cancer using genomic capture and massively parallel sequencing.
Tom Walsh, Ming K Lee, Silvia Casadei, Anne M Thornton, Sunday M Stray, Christopher Pennil, Alex S Nord, Jessica B Mandell, Elizabeth M Swisher, Mary-Claire King. Proc Natl Acad Sci U S A 2010
327
14

Disparities in genetic testing: thinking outside the BRCA box.
Michael J Hall, Olufunmilayo I Olopade. J Clin Oncol 2006
117
14



Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.